Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

Nature Medicine

Volumn 10, Issue 4, 2004, Pages 396-401

  Passage, Edith ^a   Norreel, Jean Chrétien ^a,b   Noack Fraissignes, Pauline ^a   Sanguedolce, Véronique ^a   Pizant, Josette ^a   Thirion, Xavier ^c   Robaglia Schlupp, Andrée ^a   Pellissier, Jean François ^d   Fontés, Michel ^a  

^a INSERM   (France)

^b CNRS   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; PERIPHERAL MYELIN PROTEIN 22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; FOOD AND DRUG ADMINISTRATION; HEREDITARY MOTOR SENSORY NEUROPATHY; MALE; MOUSE; MYELINATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ASCORBIC ACID; BASE SEQUENCE; CHARCOT-MARIE-TOOTH DISEASE; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MYELIN PROTEINS; PHENOTYPE; SCIATIC NERVE;

ANIMALIA;

EID: 1942422646     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1023     Document Type: Article

References (35)

1. Dyck, P.J., Oviatt, K.F. & Lambert, E.H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann. Neurol. 10, 222-226 (1981).
2. Ouvrier, R.A. & Nicholson, G.A. Advances in the genetics of hereditary hypertrophic neuropathies in childhood. Brain Dev. 17, 31-38 (1995).
3. Skre, H. Genetic and clinical aspects of Charcot-Marie-Tooth disease. Clin. Genet. 6, 98-118 (1974).
4. Boerkoel, C.F. et al. CMT disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann. Neurol. 51, 190-201 (2002).
5. Nelis, E. et al. (The European CMT Consortium). Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and HNNP: a European collaborative study. Eur. J. Hum. Genet. 4, 25-33 (1997).
6. Lupski, J.R. et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66, 219-232 (1991).
7. Raeymaekers, P. et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type la (CMT 1a). Neuromuscul. Disord. 1, 93-97 (1991).
8. Matsunami, N. et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1, 176-179 (1992).
9. Patel, P.I. et al. The gene for peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1, 159-165 (1992).
10. Timmerman, V. et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat. Genet. 1, 171-175 (1992).
11. Vatentijn, L.J. et al. The peripheral myelin protein gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1, 166-170 (1992).
12. Roa, B.B. et al. Charcot-Marie-Tooth disease type 1A: association with a spontaneous point mutation in the PMP 22 gene. N. Engl. J. Med. 329, 96-101 (1993).
13. Valentijn, L.J. et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat. Genet. 2, 288-291 (1992).
14. Fenton C.F., Schlefman, B.S. & McGlamry, E.D. Surgical considerations in the presence of Charcot-Marie-Tooth disease. J. Am. Podiatr. Assoc. 74, 490-498 (1984).
15. Gould, N. Surgery in advanced Charcot-Marie-Tooth disease. Foot Ankle 4, 267-273 (1984).
16. Njegovan, M.E., Leonard, E.I. & Joseph, F.B. Rehabilitation medicine approach to Charcot-Marie-Tooth disease. Clin. Podiatr. Med. Surg. 14, 99-116 (1997).
17. Huxley, C. et al. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5, 563-569 (1996).
18. Huxley, C. et al. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum. Mol. Genet. 7, 449-458 (1998).
19. Carey, D.J. & Todd, M.S. Schwann cell myelination in a chemically defined medium: demonstration of a requirement for additives that promote Schwann cell extracellular matrix formation. Brain Res. 429, 95-102 (1987).
20. Eldridge, C.F. et al. Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J. Cell. Biol. 105, 1023-1034 (1987).
21. Plant, G.W. et al. Purified adult ensheathing glia fail to myelinate axons under culture conditions that enable Schwann cells to form myelin. J. Neurosci. 22, 6083-6091 (2002).
22. Hood, J. Femoral neuropathy in scurvy. N. Engl. J. Med. 281, 1292-1293 (1969).
23. Norreel, J.C. et al. Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model. Eur. J. Neurosci. 13, 1625-1634 (2001).
24. Chapillon, P. et al. Early development of synchronized walking on the rotarod in rats. Effects of training and handling. Behav. Brain Res. 93, 77-81 (1998).
25. Garcia, C.A. A clinical review of Charcot-Marie-Tooth disease. Ann. NY Acad. Sci. 883, 69-76 (1999).
26. Carter, R.J. et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19, 3248-3257 (1999).
27. Sancho, S. et al. Distal axonopathy in peripheral nerves of PMP22 mutant mice. Brain 122, 1563-1577 (1999).
28. Coschigano, K.T. et al. Deletions, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144, 3799-3804 (2003).
29. Sabéran-Djoneidi, D. et al. Molecular dissection of the Schwann cell specific promoter of the PMP22gene. Gene 248, 223-231 (2000).
30. Agus, D.B. et al. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J. Clin. Invest. 100, 2842-2848 (1997).
31. 19F magnetic resonance spectroscopy. Metabolism 6, 760-770 (2003).
32. Lopez-Lluch, G. et al. Redox regulation of cAMP levels by ascorbate in 1,25-dihydroxy-vitamin D3-induced differentiation of HL-60 cells. Biochem. J. 331, 21-27 (1998).
33. Yang, Z., Copolov, D.L. & Lim, A.T. Ascorbic acid augments the adenylate cyclase-cAMP systern-mediated POMC mRNA expression and β-endorphin secretion from hypothalamic neurons in culture. Brain Res. 706, 243-248 (1996).
34. Arrigoni, O. & De Tullio, M.C. Ascorbic acid: much more than just an antioxidant. Biochim. Biophys. Acta 1569, 1-9 (2002).
35. Rodriguez-Melendez, R. Importance of water-soluble vitamins as regulatory factors of genetic expression. Rev. Invest. Clin. 54, 77-83 (2002).